Min Cui
Founder and Managing Director at Decheng Capital and a board member of Alpine Immune Sciences, Ariagen, Bioheng, CardiMED, Cue Health, EpimAb Biotherapeutics, GeneMDx, Ketai Medical, Mammoth Biosciences, and Shape Therapeutics.
Contact
- Social accounts: linkedin
Companies
Company
Roles
Nanjing Bioheng Biotech Co., Ltd.
Nanjing Bioheng Biotech Co., Ltd. is a Nanjing-based company founded in 2017 by Xiaohong He.
Investor
Investor
Decheng Capital
Decheng Capital is a Shanghai, China-based venture capital firm that invests in early and growth stage companies in the life science industry.
Board Member
Alpine Immune Sciences
Alpine Immune Sciences is a clinical-stage immunotherapy company developing treatments for cancer, autoimmune and inflammatory diseases.
Board Member